Peroxisome proliferator-activated receptor gamma coactivator 1-beta mRNA (PGC-1β mRNA)

Peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1β) mRNA is the transcript encoding a critical transcriptional coactivator that orchestrates energy metabolism and mitochondrial biogenesis (Source: NIH, PubMed). PGC-1β functions by interacting with and enhancing the activity of various transcription factors, such as nuclear respiratory factor 1 (NRF-1) and estrogen-related receptor alpha (ERRα), to regulate genes involved in oxidative phosphorylation, fatty acid oxidation, and hepatic gluconeogenesis (Source: NIH, JCI). In pathological contexts, elevated PGC-1β mRNA levels are associated with the development of non-alcoholic fatty liver disease (NAFLD), insulin resistance, and hypertriglyceridemia, as well as the metabolic reprogramming of certain cancers like colorectal and breast cancer (Source: NIH, ResearchGate). Therapeutic strategies targeting PGC-1β mRNA, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), aim to reduce its expression to mitigate lipid accumulation and improve metabolic homeostasis (Source: NIH, MDPI). However, because PGC-1β is essential for basal mitochondrial function, therapeutic modulation must be carefully managed to avoid adverse effects on energy-intensive organs like the heart and skeletal muscle (Source: NIH, PubMed).

Other names

PPARGC1B mRNAPERC mRNAERRL1 mRNAPGC-1-related estrogen receptor alpha coactivator mRNA

Antisense inhibition and RNA interference leading to mRNA degradation and reduced protein translation.